David Tucker

David Tucker has been self-employed as a consultant since 2017. In 2018, they began working as a Business Development Consultant for Monitored Therapeutics, Inc. In 2020, they moved to Exhalation Technology Ltd as Senior Director Business Development. Prior to this, they had been working for Aerocrine since 2007, where they held the role of Senior Director, Global Research Sales. Their responsibilities included targeting Bio-pharmaceutical, Clinical Research Organizations, Government and other accounts defined as national in scope. David also supported the successful commercialization of Exhaled Nitric Oxide in the US and international marketplace, established new contacts in the CRO industry, and devised strategies to better understand ways to position the NIOX-MINO into protocols to establish competitive advantage.

David Tucker attended Brigham Young University from 1986 to 1989, where they earned a Bachelor of Arts in Advertising.